Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Patrick O. Perche"'
1
Akademický článek
Prescribing Trends for Acne Vulgaris Visits in the United States
Autor: Patrick O. Perche, Gabrielle M. Peck, Lillian Robinson, Ayman Grada, Alan B. Fleischer, Steven R. Feldman
Publikováno v: Antibiotics, Vol 12, Iss 2, p 269 (2023)
Acne vulgaris is the most common reason for pediatric patients and third most common reason for adult patients to seek care from a dermatologist in the US. However, referring providers may be reluctant to initiate patients on acne treatment or certai
Externí odkaz: https://doaj.org/article/5c50572482c74fbd8e9aceb17a09772a
Zobrazit plný text záznamu
2
Patient willingness to receive full-body skin exams based on the sex and/or gender and training level of provider: a survey study
Autor: Patrick O. Perche, Varun K. Ranpariya, Ritu N. Swali, Dillon D. Clarey, Ashley Wysong, Steven R. Feldman
Publikováno v: Clinical and Experimental Dermatology. 47:1853-1856
Full-body skin examinations (FBSEs) involve examination of the patient’s skin from head to toe, and may be uncomfortable for some patients. While many patients prefer same-sex providers for pelvic, genital and rectal exams, desire for same-sex prov
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24d3b8630fde3ded488e631ea3da00d
https://doi.org/10.1111/ced.15260
Zobrazit plný text záznamu
4
Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis
Autor: Patrick O. Perche, Madison K. Cook, Steven R. Feldman
Publikováno v: Annals of Pharmacotherapy. 57:86-98
Objective The objective of this article is to review abrocitinib, an oral Janus kinase (JAK) 1 inhibitor, for the treatment of patients with moderate-to-severe atopic dermatitis (AD). Data Sources A literature search of MEDLINE (PubMed) was performed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d38ff0f4de5ef1ed0687989fdbb72c3
https://doi.org/10.1177/10600280221096713
Zobrazit plný text záznamu
5
Comparing available JAK inhibitors for treating patients with psoriasis
Autor: Parker J. Funk, Patrick O. Perche, Rohan Singh, Katherine A. Kelly, Steven R. Feldman
Publikováno v: Expert Review of Clinical Immunology. 18:281-294
Cytokine blockers have revolutionized the management of psoriasis. While efficacious, not all patients respond, and treatment may lose efficacy over time. Janus kinase (JAK) inhibitors target the Janus Kinase/Signal Transducer and Activator of Transc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d686da8de0973140fffd0d8bcd4a89e
https://doi.org/10.1080/1744666x.2022.2039121
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje